Position in JAZZ
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$4,694,111
+$305,561 QoQ
Shares Held
24,830
-3.8% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Summit Trail Advisors, LLC holds $27,745,492 across 30 Biotechnology names. JAZZ ranks #1 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
24,830 | $4,694,111 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,247 | $3,236,075 | |
| 3 | INCY |
Incyte Corp
|
27,019 | $2,543,028 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,017 | $2,331,054 | |
| 5 | TECH |
BIO-TECHNE Corp
|
35,002 | $1,829,204 | |
| 6 | RPRX |
Royalty Pharma plc
|
33,611 | $1,612,319 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,598 | $1,190,470 | |
| 8 | INSM |
INSMED Inc
|
6,714 | $1,097,873 |
All Filings in JAZZ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,694,111 | 24,830 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,388,550 | 25,815 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,899,072 | 21,996 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,521,017 | 14,333 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $417,144 | 3,360 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $538,904 | 4,376 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||